TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

Boussard & Gavaudan Investment Management LLP's Holding History (CIK: 0001614986)

Note: Option positions (PUT/CALL) are excluded.

Q4 2022
Shares 3,800 Value ($000) $3,470 Avg Close — Range —
Q3 2022
Shares 3,800 Value ($000) $4,011 Avg Close — Range —